Silver Domus is IM Gestão de Ativos' thematic bet on Portuguese senior care: a closed-end venture capital fund (CMVM code 2275) backing operators of care homes, continuing-care units and home-care services, with a €120 million fundraising target. The demographic logic is easy to follow. The decisive complication is that Golden Visa eligibility is genuinely unresolved: directory data contradicts itself on the question, and the manager makes no visa claim at all.
Key takeaways
- Closed-end Portuguese FCR, CMVM code 2275, investing in senior-living operators: care homes (ERPIs), continuing-care units, home-care and specialised care, concentrated in Lisbon and Porto.
- Golden Visa eligibility is contested: the same directory record flags it eligible and, in its own FAQ, states it is not compliant with post-2023 rules. IMGA makes no Golden Visa claim.
- Reported €50,000 minimum for qualified investors, with a €120M target raise; directory tags separately suggest €500k+, so the current minimum needs confirming.
- No redemptions before termination, no published fund term, no NAV series, and no fee schedule beyond a single-sourced 1.5% management figure.
- Nothing is published on US-investor acceptance or PFIC/QEF treatment.
Is Silver Domus eligible for the Portugal Golden Visa?
This is the question that decides whether the fund belongs on a visa shortlist at all, and right now it has no reliable answer. The directory record that covers the fund flags it as Golden Visa eligible, citing a manager attestation and a 100% Portugal allocation. The FAQ on that same page states the opposite: that Silver Domus is not Golden Visa compliant because its structure and investment focus do not meet the post-2023 ARI requirements.
The substance behind the contradiction is real. Since October 2023, funds with direct or indirect real-estate exposure do not qualify. Senior-living ventures, care homes, continuing-care units, are intrinsically tied to physical facilities, so indirect real-estate exposure is plausible depending on how the portfolio companies hold their premises. That is exactly the kind of structural detail only the fund's own documents can settle.
What tips the balance toward caution is the manager's silence. IMGA markets several funds explicitly toward Golden Visa investors elsewhere in its range; for Silver Domus, it makes no such claim.
Golden Visa eligibility for Silver Domus is unresolved: the directory evidence directly contradicts itself, the strategy's link to care facilities makes indirect real-estate exposure plausible under the post-2023 rules, and IMGA makes no eligibility claim. Anyone considering this fund for a visa application should obtain a written legal eligibility opinion before committing capital. Without one, treat it purely as a qualified-investor private-markets fund.
What does the fund actually invest in?
The strategy targets Portugal's senior-living sector in its various forms: residential structures for the elderly (ERPIs), continuing-care units (UCCs), home care and specialised care. IMGA's launch plan paired two engines: partnerships with established operators running more than 1,000 beds, and an expansion programme toward roughly 4,500 beds nationwide, concentrated in Lisbon and Porto. A second phase, branded "Senior Campus", would add independent senior living.
The demographic thesis needs little defence. Portugal is one of Europe's oldest countries with a chronic shortage of quality senior-care capacity, and the manager, Portugal's largest independent asset manager, lends institutional weight to a niche strategy. Directory data records the geographic allocation as 100% Portugal, and IMGA's launch plan split the assisted-living exposure roughly 65% ERPIs and 35% continuing-care units.
What is missing is the portfolio itself. No holdings, no operator names, no deployment figures. There is also a timeline puzzle: IMGA announced the fund and its €120 million target in late 2021, yet the fund page shows a CMVM registration date of 14 October 2025, and the project's path between those dates is not explained anywhere public.
What would the fees cost you?
Honest answer: nobody outside the subscription process knows. The only fee figure in circulation is a 1.5% management fee reported by a single aggregator and confirmed nowhere in manager documents. Performance fee, hurdle, subscription and redemption charges, custodian and auditor: all unpublished.
For orientation only, the reported 1.5% on a €500,000 Golden Visa-scale subscription would imply about €7,500 per year, roughly €45,000 over six years and €52,500 over seven. On the €50,000 minimum reported for qualified investors, the same rate implies about €750 per year. Both calculations rest on an unverified rate and an unknown fee base, and the fund's term is itself unpublished, so the total holding period the fees would run for is unknown too.
The practical takeaway is procedural rather than numerical. The fee schedule, the regulation and the term sheet exist; they simply are not public. Request them before any other diligence step.
Liquidity, lock-up and the citizenship timeline
Silver Domus is a fully committed vehicle. As a closed-end FCR there are no redemptions during the fund's life: exit comes at termination, through asset liquidation, or via a secondary transfer of units where permitted, which in practice means case-by-case and dependent on finding a buyer. No explicit lock-up period is published because the whole structure is the lock-up.
There is no NAV to watch along the way either. No daily or monthly NAV is published; valuations are periodic, arriving through semi-annual and annual reports.
Mapping this against the citizenship clock is harder than usual because the fund's term is not published. Portuguese naturalization tends to run roughly six to seven years in practice, and a closed-end venture fund of this type would normally outlast that. But without a stated term, an investor cannot even estimate whether capital returns before, at, or well after the citizenship milestone. That is an unusual gap for a fund being discussed in a Golden Visa context, and another item for the written-questions list.
What should US citizens know?
Nothing is published, which is itself the finding. Neither the manager nor any aggregator addresses whether US persons are accepted; the directory's own field records the status as unknown. PFIC classification, QEF reporting and IRA eligibility are equally unaddressed.
The default assumptions are unfavourable. As a non-US closed-end fund, Silver Domus would generally be a PFIC for US taxpayers. Without a QEF election, supported by annual information statements the manager would have to commit to providing, gains fall into the default PFIC regime of top ordinary rates plus an interest charge. Some Portuguese funds do provide QEF support; whether this one would is simply unknown.
A US investor's diligence here starts from zero: written confirmation of US-person acceptance, PFIC statement delivery and FATCA handling, reviewed with a US tax adviser, before anything else.
How does it compare with other Golden Visa funds?
Within our database, Silver Domus sits in the venture capital category with an unusual profile. Its reported €50,000 first-phase minimum is below the €100,000 ticket typical of the wider universe, though the conflicting €500k+ directory tag muddies that. Its reported 1.5% management fee, if accurate, sits at the lower edge of the roughly 1.5-2% band common among Golden Visa funds, but with the rest of the fee stack unknown, the comparison is incomplete.
The sharper contrast is disclosure. Same-manager alternatives show what the fuller picture can look like: IMGA Futurum Tech is a closed-end VC fund with a reported US/QEF posture, and IMGA GV Portuguese Equities is an explicitly Golden Visa-branded vehicle at the liquid end of the spectrum. Silver Domus is the thinnest-disclosure entry in the IMGA range we track. The full landscape is in our fund database.
What the fund has not published
Listed for completeness; their weight depends on your situation. Golden Visa eligibility, with directly conflicting directory statements and no manager claim. Fund term and lock-up. The fee schedule beyond the unverified 1.5% figure. Custodian and auditor. Current fund size and capital raised against the €120M target. Why a fund announced in late 2021 shows a CMVM registration date of October 2025. US-investor acceptance and PFIC/QEF treatment. An ISIN, with only the LEI (8755004X4U4JVQFB3C81) public. There is also no target return: IMGA's 2021 announcement spoke only of expected profitability without a figure, and no distribution schedule backs the directory's income-focused tags.
Next step
If Portuguese senior-care demographics appeal and you qualify as a professional or qualified investor, the path runs through documents IMGA has not made public: the management regulation, the fee schedule, the fund term, and above all a written Golden Visa eligibility opinion if a visa is the goal. Roots can walk you through the materials and the alternatives independently, without a sales agenda. This is information, not investment, tax or immigration advice; capital is at risk and visa outcomes are never guaranteed.
